DZ2933A1 - Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant. - Google Patents

Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant.

Info

Publication number: DZ2933A1
Authority: DZ; Algeria
Prior art keywords: azabicydilic; benzisoxazole; ethyl; substituted; compounds
Prior art date: 1998-12-28

Application number

DZ990233A

Other languages

English (en)

French (fr)

Inventor

Gene Michael Bright

Kishor Amratlal Desai

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-28

Filing date

1999-11-10

Publication date

2004-03-15

1999-11-10 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DZ2933A1 publication Critical patent/DZ2933A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Diabetes (AREA)
Addiction (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DZ990233A 1998-12-28 1999-11-10 Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant. DZ2933A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11395798P	1998-12-28	1998-12-28

Publications (1)

Publication Number	Publication Date
DZ2933A1 true DZ2933A1 (fr)	2004-03-15

Family

ID=22352526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990233A DZ2933A1 (fr)	1998-12-28	1999-11-10	Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant.

Country Status (43)

Country	Link
US (1)	US6525196B1 (xx)
EP (1)	EP1140931B1 (xx)
JP (1)	JP2002533463A (xx)
KR (1)	KR100417506B1 (xx)
CN (1)	CN1332740A (xx)
AP (1)	AP2001002188A0 (xx)
AR (1)	AR024840A1 (xx)
AT (1)	ATE260278T1 (xx)
AU (1)	AU761711B2 (xx)
BG (1)	BG105710A (xx)
BR (1)	BR9916807A (xx)
CA (1)	CA2356985C (xx)
CO (1)	CO5150179A1 (xx)
CR (1)	CR6398A (xx)
CZ (1)	CZ291163B6 (xx)
DE (1)	DE69915113T2 (xx)
DK (1)	DK1140931T3 (xx)
DZ (1)	DZ2933A1 (xx)
EA (1)	EA003099B1 (xx)
EE (1)	EE04439B1 (xx)
ES (1)	ES2214892T3 (xx)
GE (1)	GEP20043227B (xx)
GT (1)	GT199900224A (xx)
HR (1)	HRP20010488A2 (xx)
HU (1)	HUP0104852A3 (xx)
ID (1)	ID30117A (xx)
IL (1)	IL143385A0 (xx)
IS (1)	IS5951A (xx)
MA (1)	MA26706A1 (xx)
NO (1)	NO20013215L (xx)
NZ (1)	NZ511964A (xx)
OA (1)	OA11742A (xx)
PA (1)	PA8486701A1 (xx)
PE (1)	PE20001234A1 (xx)
PT (1)	PT1140931E (xx)
SK (1)	SK9002001A3 (xx)
TN (1)	TNSN99218A1 (xx)
TR (1)	TR200101979T2 (xx)
TW (1)	TW523514B (xx)
UA (1)	UA62015C2 (xx)
WO (1)	WO2000039128A1 (xx)
YU (1)	YU44301A (xx)
ZA (1)	ZA200105041B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE409475T1 (de) *	2001-02-20	2008-10-15	Dinan Timothy Gerard	Behandlung von fibromyalgie mit pindolol
GB0203778D0 (en) *	2002-02-18	2002-04-03	Glaxo Group Ltd	Compounds
EP1608648B1 (en) *	2003-03-12	2012-07-18	Pfizer Products Inc.	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
GB0316915D0 (en) *	2003-07-18	2003-08-20	Glaxo Group Ltd	Compounds
JP2007519705A (ja) *	2004-01-29	2007-07-19	ファイザー・プロダクツ・インク	Ｃｎｓ障害を治療するための非定型抗精神病薬とアミノメチルピリジルオキシメチル／ベンゾイソオキサゾールアザビシクロ誘導体の組合せ
AR048112A1 (es) *	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
AR049478A1 (es)	2004-03-25	2006-08-09	Solvay Pharm Bv	Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
BRPI0515143A (pt) *	2004-09-10	2008-07-08	Pfizer Prod Inc	usos de derivados azabicìclicos de piridiloximetila e benzisoxazol para a preparação de uma composição farmacêutica para o tratamento dos distúrbios de humor
MX2007002842A (es) *	2004-09-10	2007-04-30	Pfizer Prod Inc	Metodos de tratamiento de trastornos cognitivos que usan derivados azabiciclicos de piridiloximetilo y benzoisoxazol.
DE102005026194A1 (de) *	2005-06-06	2006-12-07	Grünenthal GmbH	Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
WO2008019431A1 (en) *	2006-08-14	2008-02-21	Brc Operations Pty Limited	Method and compositions for simultaneously regulating memory and mood
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer
WO2021127391A1 (en) *	2019-12-20	2021-06-24	The Jackson Laboratory	Molecular targets for addiction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5157034A (en) *	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
US5756496A (en) *	1994-05-28	1998-05-26	Smithkline Beecham P.L.C.	Amide derivatives having 5HT1D-antagonist activity
WO1998050358A1 (en) *	1997-04-18	1998-11-12	Smithkline Beecham Plc	Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
IT1293807B1 (it) *	1997-08-01	1999-03-10	Recordati Chem Pharm	Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
PA8469101A1 (es) *	1998-04-09	2000-09-29	Pfizer Prod Inc	Ligandos azabiciclicos de receptores 5ht1

1999
- 1999-03-11 UA UA2001064492A patent/UA62015C2/uk unknown
- 1999-04-11 AR ARP990105589A patent/AR024840A1/es unknown
- 1999-11-03 DK DK99951040T patent/DK1140931T3/da active
- 1999-11-03 ID IDW00200101401A patent/ID30117A/id unknown
- 1999-11-03 KR KR10-2001-7008261A patent/KR100417506B1/ko not_active IP Right Cessation
- 1999-11-03 SK SK900-2001A patent/SK9002001A3/sk unknown
- 1999-11-03 BR BR9916807-3A patent/BR9916807A/pt not_active Application Discontinuation
- 1999-11-03 JP JP2000591039A patent/JP2002533463A/ja active Pending
- 1999-11-03 YU YU44301A patent/YU44301A/sh unknown
- 1999-11-03 AT AT99951040T patent/ATE260278T1/de not_active IP Right Cessation
- 1999-11-03 AU AU63614/99A patent/AU761711B2/en not_active Ceased
- 1999-11-03 NZ NZ511964A patent/NZ511964A/en unknown
- 1999-11-03 TR TR2001/01979T patent/TR200101979T2/xx unknown
- 1999-11-03 EE EEP200100346A patent/EE04439B1/xx not_active IP Right Cessation
- 1999-11-03 EP EP99951040A patent/EP1140931B1/en not_active Expired - Lifetime
- 1999-11-03 DE DE69915113T patent/DE69915113T2/de not_active Expired - Fee Related
- 1999-11-03 PT PT99951040T patent/PT1140931E/pt unknown
- 1999-11-03 GE GEAP19995963A patent/GEP20043227B/en unknown
- 1999-11-03 CN CN99815202A patent/CN1332740A/zh active Pending
- 1999-11-03 IL IL14338599A patent/IL143385A0/xx unknown
- 1999-11-03 CA CA002356985A patent/CA2356985C/en not_active Expired - Fee Related
- 1999-11-03 AP APAP/P/2001/002188A patent/AP2001002188A0/en unknown
- 1999-11-03 CZ CZ20012386A patent/CZ291163B6/cs not_active IP Right Cessation
- 1999-11-03 EA EA200100517A patent/EA003099B1/ru not_active IP Right Cessation
- 1999-11-03 ES ES99951040T patent/ES2214892T3/es not_active Expired - Lifetime
- 1999-11-03 HU HU0104852A patent/HUP0104852A3/hu unknown
- 1999-11-03 OA OA1200100172A patent/OA11742A/en unknown
- 1999-11-03 WO PCT/IB1999/001772 patent/WO2000039128A1/en active IP Right Grant
- 1999-11-04 PE PE1999001116A patent/PE20001234A1/es not_active Application Discontinuation
- 1999-11-05 TW TW088119374A patent/TW523514B/zh not_active IP Right Cessation
- 1999-11-10 DZ DZ990233A patent/DZ2933A1/xx active
- 1999-11-10 MA MA25844A patent/MA26706A1/fr unknown
- 1999-11-17 TN TNTNSN99218A patent/TNSN99218A1/fr unknown
- 1999-11-18 CO CO99072703A patent/CO5150179A1/es unknown
- 1999-12-06 US US09/454,509 patent/US6525196B1/en not_active Expired - Fee Related
- 1999-12-07 PA PA19998486701A patent/PA8486701A1/es unknown
- 1999-12-23 GT GT199900224A patent/GT199900224A/es unknown
2001
- 2001-05-22 IS IS5951A patent/IS5951A/is unknown
- 2001-06-19 CR CR6398A patent/CR6398A/es not_active Application Discontinuation
- 2001-06-20 ZA ZA200105041A patent/ZA200105041B/en unknown
- 2001-06-27 NO NO20013215A patent/NO20013215L/no not_active Application Discontinuation
- 2001-06-28 HR HR20010488A patent/HRP20010488A2/hr not_active Application Discontinuation
- 2001-07-16 BG BG105710A patent/BG105710A/xx unknown

Also Published As

Publication number	Publication date
DE69915113T2 (de)	2004-08-26
EP1140931A1 (en)	2001-10-10
WO2000039128A1 (en)	2000-07-06
CA2356985A1 (en)	2000-07-06
CA2356985C (en)	2006-08-08
US6525196B1 (en)	2003-02-25
MA26706A1 (fr)	2004-12-20
CO5150179A1 (es)	2002-04-29
NZ511964A (en)	2003-08-29
CZ20012386A3 (cs)	2002-02-13
CN1332740A (zh)	2002-01-23
HUP0104852A3 (en)	2002-12-28
CZ291163B6 (cs)	2003-01-15
DE69915113D1 (de)	2004-04-01
NO20013215L (no)	2001-08-27
KR100417506B1 (ko)	2004-02-05
HUP0104852A2 (hu)	2002-05-29
IL143385A0 (en)	2002-04-21
IS5951A (is)	2001-05-22
AR024840A1 (es)	2002-10-30
AU761711B2 (en)	2003-06-05
EA003099B1 (ru)	2002-12-26
PA8486701A1 (es)	2000-09-29
BR9916807A (pt)	2001-10-23
YU44301A (sh)	2004-07-15
NO20013215D0 (no)	2001-06-27
AU6361499A (en)	2000-07-31
EA200100517A1 (ru)	2001-12-24
AP2001002188A0 (en)	2001-06-30
OA11742A (en)	2005-05-13
HRP20010488A2 (en)	2002-08-31
EE200100346A (et)	2002-12-16
TW523514B (en)	2003-03-11
BG105710A (en)	2002-02-28
EP1140931B1 (en)	2004-02-25
ES2214892T3 (es)	2004-09-16
KR20010092455A (ko)	2001-10-25
GEP20043227B (en)	2004-04-26
DK1140931T3 (da)	2004-04-19
EE04439B1 (et)	2005-02-15
ATE260278T1 (de)	2004-03-15
GT199900224A (es)	2001-06-15
PT1140931E (pt)	2004-05-31
ZA200105041B (en)	2002-06-20
SK9002001A3 (en)	2002-04-04
CR6398A (es)	2004-03-24
ID30117A (id)	2001-11-08
TR200101979T2 (tr)	2001-12-21
PE20001234A1 (es)	2000-11-07
JP2002533463A (ja)	2002-10-08
TNSN99218A1 (fr)	2005-11-10
UA62015C2 (en)	2003-12-15

Publication	Publication Date	Title
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26463A1 (fr)	2004-12-20	Nouvelles sulfones cycliques, leur procede de production et composition pharmaceutique les contenant
DZ2889A1 (fr)	2003-12-15	4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
FR2718136B1 (fr)	1996-06-21	Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
DZ2395A1 (fr)	2003-06-04	Composés nouveaux a noyau dibenzocycloheptène procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2697A1 (fr)	2003-03-29	Composés azapolycycliques à noyau aryle condensé procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2933A1 (fr)	2004-03-15	Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant.
DZ2978A1 (fr)	2004-07-04	Composés chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA24529A1 (fr)	1998-12-31	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2944A1 (fr)	2004-03-15	Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.
DZ2045A1 (fr)	2002-07-21	Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2753A1 (fr)	2005-09-15	Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
MA26558A1 (fr)	2004-12-20	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2567131B1 (fr)	1991-06-07	Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
MA26624A1 (fr)	2004-12-20	Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2655A1 (fr)	2003-03-22	Trifluorométhyléthers cycliques à fonction pipéridinylaminoéthyle procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2796A1 (fr)	2003-12-01	Composés à fonction bis-aminométhyl-carbonyle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26552A1 (fr)	2004-12-20	Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.